En­do reach­es opi­oid set­tle­ment in Flori­da; De­moc­rats call on CMS to low­er pre­mi­ums fol­low­ing Aduhelm price cut

As the opi­oid epi­dem­ic con­tin­ues to rav­age the coun­try, and as law­suits against opi­oid de­vel­op­ers and dis­trib­u­tors end­ed in bank­rupt­cies and set­tle­ments, one com­pa­ny says it’s re­solv­ing all such claims in Flori­da.

En­do Phar­ma­ceu­ti­cals reached a set­tle­ment with the state for $65 mil­lion, the com­pa­ny an­nounced Tues­day, though it in­cludes “no ad­mis­sion of wrong­do­ing, fault or li­a­bil­i­ty of any kind by En­do or its sub­sidiaries.” The set­tle­ment comes as the case was set to go to tri­al in April.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER